NGM Biopharmaceuticals, Inc is a biotechnology business based in the US. NGM Biopharmaceuticals shares (NGM) are listed on the NASDAQ and all prices are listed in US Dollars. NGM Biopharmaceuticals employs 210 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in NGM Biopharmaceuticals
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – NGM – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
NGM Biopharmaceuticals stock price (NASDAQ: NGM)Use our graph to track the performance of NGM stocks over time.
NGM Biopharmaceuticals shares at a glance
|Latest market close||$15.06|
|52-week range||$14.90 - $32.12|
|50-day moving average||$20.05|
|200-day moving average||$25.24|
|Wall St. target price||$24.50|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.46|
Buy NGM Biopharmaceuticals shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy NGM Biopharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
NGM Biopharmaceuticals price performance over time
|1 week (2021-07-15)||N/A|
|1 month (2021-06-25)||-29.40%|
|3 months (2021-04-26)||-45.98%|
|6 months (2021-01-22)||N/A|
|1 year (2020-07-22)||N/A|
|2 years (2019-07-22)||N/A|
|3 years (2018-07-22)||N/A|
|5 years (2016-07-22)||N/A|
NGM Biopharmaceuticals financials
|Revenue TTM||$84.6 million|
|Gross profit TTM||$-76,604,000|
|Return on assets TTM||-17.21%|
|Return on equity TTM||-30.87%|
|Market capitalisation||$1.7 billion|
TTM: trailing 12 months
Shorting NGM Biopharmaceuticals shares
There are currently 2.1 million NGM Biopharmaceuticals shares held short by investors – that's known as NGM Biopharmaceuticals's "short interest". This figure is 15.3% down from 2.5 million last month.
There are a few different ways that this level of interest in shorting NGM Biopharmaceuticals shares can be evaluated.
NGM Biopharmaceuticals's "short interest ratio" (SIR)
NGM Biopharmaceuticals's "short interest ratio" (SIR) is the quantity of NGM Biopharmaceuticals shares currently shorted divided by the average quantity of NGM Biopharmaceuticals shares traded daily (recently around 535145.52429668). NGM Biopharmaceuticals's SIR currently stands at 3.91. In other words for every 100,000 NGM Biopharmaceuticals shares traded daily on the market, roughly 3910 shares are currently held short.
However NGM Biopharmaceuticals's short interest can also be evaluated against the total number of NGM Biopharmaceuticals shares, or, against the total number of tradable NGM Biopharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case NGM Biopharmaceuticals's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 NGM Biopharmaceuticals shares in existence, roughly 30 shares are currently held short) or 0.0568% of the tradable shares (for every 100,000 tradable NGM Biopharmaceuticals shares, roughly 57 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against NGM Biopharmaceuticals.
Find out more about how you can short NGM Biopharmaceuticals stock.
NGM Biopharmaceuticals share dividends
We're not expecting NGM Biopharmaceuticals to pay a dividend over the next 12 months.
NGM Biopharmaceuticals share price volatility
Over the last 12 months, NGM Biopharmaceuticals's shares have ranged in value from as little as $14.9 up to $32.12. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while NGM Biopharmaceuticals's is 2.0134. This would suggest that NGM Biopharmaceuticals's shares are significantly more volatile than the average for this exchange and represent a higher risk.
NGM Biopharmaceuticals overview
NGM Biopharmaceuticals, Inc. , a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trials for the treatment of non-alcoholic steatohepatitis (NASH); and MK-3655, an agonistic antibody that activates fibroblast growth factor receptor 1c-beta-klotho, which is in Phase IIb clinical trial for use in the treatment of type 2 diabetes and NASH. Its products under development also comprise NGM120, an inhibitory antibody binding glial cell-derived neurotrophic factor receptor alpha-like that is in Phase Ib clinical trials to inhibit growth differentiation factor GDF15 levels on cancer anorexia/cachexia syndrome; NGM621, an antibody in Phase II clinical trials for the treatment of geographic atrophy; and NGM707 and NGM438, which are in preclinical investigational studies for the treatment of advanced solid tumors. The company has research collaboration, product development, and license agreements with Merck Sharp & Dohme Corp. NGM Biopharmaceuticals, Inc. was incorporated in 2007 and is headquartered in South San Francisco, California.
Stocks similar to NGM Biopharmaceuticals
NGM Biopharmaceuticals in the news
What Makes NGM Biopharmaceuticals (NGM) a New Buy Stock
The Daily Biotech Pulse: Acorda Spikes On Distribution Deal, Alzamend Soars On Data, Pfizer-BioNTech To Supply More Vaccine Doses, 3 IPOs
NGM Announces Completion of Enrollment in Phase 2 CATALINA Study of NGM621 in Patients with Geographic Atrophy Secondary to Age-Related Macular Degeneration
Frequently asked questionsWhat percentage of NGM Biopharmaceuticals is owned by insiders or institutions?
Currently 24.76% of NGM Biopharmaceuticals shares are held by insiders and 67.775% by institutions. How many people work for NGM Biopharmaceuticals?
Latest data suggests 210 work at NGM Biopharmaceuticals. When does the fiscal year end for NGM Biopharmaceuticals?
NGM Biopharmaceuticals's fiscal year ends in December. Where is NGM Biopharmaceuticals based?
NGM Biopharmaceuticals's address is: 333 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 What is NGM Biopharmaceuticals's ISIN number?
NGM Biopharmaceuticals's international securities identification number is: US62921N1054 What is NGM Biopharmaceuticals's CUSIP number?
NGM Biopharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 62921N105
More guides on Finder
How to buy Clover Finance (CLV) in the US
This guide will show you step-by-step instructions on how to buy the Clover Finance (CLV) token as well as a list of exchanges you can trade it on.
How to buy AT-and-T (T) stock
Steps to owning and managing T, with 24-hour and historical pricing before you buy.
How to buy Hellenic Coin (HNC) in the US
This guide will show you step-by-step instructions on how to buy the Hellenic Coin (HNC) token as well as a list of exchanges you can trade it on.
How to buy Maro (MARO) in the US
This guide will show you step-by-step instructions on how to buy the Maro (MARO) token as well as a list of exchanges you can trade it on.
How to buy Ethernity Chain (ERN) in the US
This guide will show you step-by-step instructions on how to buy the Ethernity Chain (ERN) token as well as a list of exchanges you can trade it on.
How to buy Shopping.io (SPI) in the US
This guide will show you step-by-step instructions on how to buy the Shopping.io (SPI) token as well as a list of exchanges you can trade it on.
How to buy LUKSO Token (LYXE) in the US
This guide will show you step-by-step instructions on how to buy the LUKSO Token (LYXE) token as well as a list of exchanges you can trade it on.
How to buy KardiaChain (KAI) in the US
This guide will show you step-by-step instructions on how to buy the KardiaChain (KAI) token as well as a list of exchanges you can trade it on.
How to buy Neutrino USD (USDN) in the US
This guide will show you step-by-step instructions on how to buy the Neutrino USD (USDN) token as well as a list of exchanges you can trade it on.
How to buy Venus BTC (VBTC) in the US
This guide will show you step-by-step instructions on how to buy the Venus BTC (VBTC) token as well as a list of exchanges you can trade it on.
Ask an Expert